Objective: Sleep State Misperception insomnia has been commonly viewed as a perceptual or psychological problem. It was hypothesized that Sleep State Misperception insomnia, like psychophysiological insomnia, could be associated with increased physiological activation, here indexed by whole body metabolic rate. Method: Groups of nine patients with Sleep State Misperception insomnia and age-, sex-, and weight-matched normal sleepers were evaluated on sleep, performance, mood, personality, and metabolic measures over a 36-hour sleep laboratory stay. Results: Sleep State Misperception insomniacs had a subjective history of poor sleep and perceived their laboratory sleep as poor but had electroencephalogram (EEG) parameters that did not differ statistically from matched normal controls. Sleep State Misperception insomniacs had abnormal MMPI values and were subjectively more confused, tense, depressed, and angry than matched normals. Sleep State Misperception insomniacs also had a significantly increased 24-hour metabolic rate, compared with matched normals. Conclusions: The overall increase in whole body oxygen use was less than that seen in psychophysiological insomniacs but was consistent with the view that Sleep State Misperception insomnia may be a mild version or a precursor to psychophysiological insomnia.
INTRODUCTION
Patients with primary insomnia complain of poor sleep as well as other symptoms including subjective fatigue (1, 2) and increased stress, anxiety, or depression (1, 2) in addition to poor sleep. Sleep laboratory evaluations of these patients have also documented long latencies or inability to fall asleep on the Multiple Sleep Latency Test (MSLT) (1, (3) (4) (5) ; psy-chopathology as measured by the Minnesota Multiphasic Personality Inventory (MMPI) (6) ; increased physiological activation as indexed by measures such as body temperature (7) (8) (9) , whole body metabolic rate (1), or heart rate (7, (10) (11) (12) (13) ; and consistent overestimation of sleep latency and time spent awake during the night (14, 15) .
A subgroup of these insomnia patients was found to have normal amounts of sleep when evaluated by objective electroencephalogram (EEG) criteria despite their subjective claims of increased sleep latency and decreased nocturnal sleep time. Such patients are currently given the diagnosis of Sleep State Misperception (SSM) (16) . Some investigators believe that SSM is a sleep laboratory artifact because the natural variability of sleep parameters in patients with insomnia is such that they would be expected to have a good night of sleep occasionally, and these occasions could occur at times on sleep laboratory evaluation nights (17) . However, a study designed specifically to address this issue found that sleep times in a group of true insomniacs remained consistently low on six sleep laboratory evaluation nights over a 3-month period whereas sleep times in a group of SSM patients remained consistently high over the same period of time (18) . Despite consistent high sleep times, the SSM patients continued to rate their sleep time to be less than that recorded.
Recently, it has been suggested that primary insomnia is actually a disorder of central nervous system hyperarousal. Many studies have shown that patients with primary insomnia have increased physiological activation as indexed by measures such as body temperature, heart rate, and whole body metabolic rate. In normal young adults, physiological activation by the use of caffeine produced many of the primary and secondary symptoms of patients with insomnia (19) , but poor sleep without the physiological activation did not produce the secondary symptoms (20) . The inability of an insomniac sleep pattern to produce increased latencies on the MSLT, increased body temperature, increased tension, personality change, or overestimation of sleep parameters suggests that a factor other than EEG sleep is responsible for the production of the insomnia symptom complex (20) . Because hyperarousal by itself does produce poor sleep, increased MSLT latencies, increased metabolic rate, increased body temperature, increased tension, decreased vigor, and increased personality disturbance (5), a role for hyperarousal in the production of insomnia is clear. It is possible that hyperarousal could cause a secondary symptom such as poor EEG sleep in insomniacs with a weaker sleep system (eg, elderly individuals), but not in others with a stronger sleep system (eg, young adults) although all patients might suffer from hyperarousal (symptoms such as increased physiological arousal, subjective fatigue, or misperception of sleep parameters).
One report has examined specifically the relationship between physiological arousal and subjective estimation of sleep parameters in several groups of insomniac and normal sleepers (21) . It was shown that decreasing arousal level either by administration of benzodiazepines or by sleep deprivation decreased the ratio of subjective to objective sleep latencies in both normals and insomniacs. Similarly, increasing arousal level by administering caffeine or altering the circadian placement of sleep onset (ie, daytime sleep periods) increased the ratio of subjective to objective sleep latencies. The finding of longer subjective latencies compared with EEG latencies with increasing levels of arousal remained, even when the increased likelihood of overestimating long sleep latencies was taken into account.
These findings have resulted in the hypothesis that patients with Sleep State Misperception suffer from a hyperarousal disorder. As such, these patients should have subjective complaints similar to those of patients with psychophysiological insomnia and evidence of hyperarousal despite relatively normal sleep patterns. The current study was designed to compare whole body metabolic rate in patients with SSM to matched normal control sleepers.
METHOD

Subjects
Subjects (Ss) were required to be healthy, 18-to 50-year-old men and women. Potential Ss were solicited from sleep center referrals and from advertisements in the local papers for participants in sleep research. This study took place in an urban Department of Veterans Affairs Medical Center. As such, an increased incidence of male referrals was expected.
Misperception Insomniacs
After completing a screening questionnaire, individuals were considered further who indicated that they had a sleep problem, and that it took 45 minutes or more to fall asleep at least 4 nights each week, or that they were awake for 60 minutes or more each night after falling asleep for at least 4 nights each week, and that this condition had existed for at least 1 year.
Exclusions
Potential subjects who indicated excessive caffeine consumption (more than 250 mg of caffeine per day), who were using psychoactive medication or drugs, or who had completed a drug or alcohol abuse program within the previous year were excluded. Ss with a history of depression or psychiatric hospitalization or a t score above 70 on a screening version of the depression scale of the MMPI were excluded. Potential Ss who had histories strongly suggestive of circadian desynchrony (eg, shift workers), sleep apnea, or periodic leg movements were excluded.
Subjects meeting the above criteria were invited to participate in the study after completing an informed consent and 2 hours of acclimatization to the laboratory with practice on computer tests and questionnaires to be used in the study.
Patients who demonstrated normal sleep (sleep latency < 30 minutes and sleep efficiency > 90%) despite their claim of insomnia, who overestimated their sleep latency by at least 100% on both nights, and who had sleep latency estimates of 20 minutes or more on both nights were accepted as Sleep State Misperception insomniacs.
Normals
Normals were required to indicate normal sleep on their screening questionnaire. They also were required to report a sleep latency of < 30 minutes and < 30 minutes of wake time during the night. In addition, normal subjects were required to match a qualified SSM patient by sex, age (within 5 years), weight (within 25 pounds), and general time in bed characteristics. To qualify for the study as a normal, individuals were required to have EEG sleep latencies of < 30 minutes and to have a sleep efficiency > 90% on both nights (and not to have sleep apnea or leg movements as defined above).
Design
After practice, subjects were scheduled to spend 2 nights and the intervening day in the laboratory. On both nights, a standard clinical polysomnogram, including two eye channels, central and occipital EEG channels, chin and leg electromyogram (EMG) channels, EKG, airflow, and chest movements, was performed. On the first night, SaO 2 was also recorded. On the second night, metabolic measures and a time code were recorded instead of SaO 2 . Sleep recordings were scored in 30-second epochs using standard Rechtschaffen and Kales criteria (22) . EEG arousals were scored using American Sleep Disorders Association [ASDA) criteria (23) . Sleep latency was defined as the period of time from the beginning of the recording to the first epoch of any stage of sleep. Rapid eye movement (REM) latency was defined as the period of time from the first epoch of any stage of sleep to the first epoch of REM sleep.
A schematic of the tests and times is presented in Table 1 . On the morning of the day spent at the laboratory, an initial 20-minute metabolic measurement was performed immediately after awakening. Ss performed computer tests, completed a MMPI and a sleep history, and were fed the same daily menu of food prepared at the laboratory during the day. Caffeinated beverages were not available. Subjects usually did not leave the laboratory during this day and did not engage in any activity more vigorous than walking to the bathroom. After the second night in the laboratory, subjects completed some brief computer tests and were allowed to leave.
All subjects were assigned their own room for the course of the study. Each room contained a standard hospital bed and furniture including a desk with an Apple IIGS computer. Subjects participated in the study in groups of one to two individuals. Subjects completed all tests and questionnaires at their individual computer workstation in their room under observation by a technician 
Tests
Performance and mood were assessed with a battery of measures including the memory and search task [MAST-one, three, and five letters, (24)], proofreading (10 minutes), hand tremor (2 minutes insertion of a stylus into a 4-mm opening with per cent of side touching time measured), a 5-minute digit symbol substitution task from the Wechsler Adult Intelligence Scale (WAIS) (25) , computer-modified Williams Word Memory Test of immediate free recall (26) , visual vigilance (30 minutes) (27) , subjective sleepiness (10-point analog scale), Profile of Mood States (POMS), and oral temperature. The tests were administered in repeated batteries, and the scheduling and contents of batteries are summarized in Table 1 .
For all subjects on all measures except MSLT, performance during continuous operations was scored automatically by the computer and saved in a format suitable for statistical analysis.
MSLT Recordings
Four-channel sleep recordings (LE -A2, RE-A2, C3-A2, O2-A1) were made during MSLT evaluations. Six MSLT evaluations were made during the study (at 10:00 AM, 12:00 N, and 2:00, 4:00, 6:00, and 8:00 PM). 
Metabolic Measurements
All metabolic measurements were performed with a SensorMedics Deltatrac Metabolic Monitor as described in previous studies (1, 20, 28) . This metabolic cart was designed specifically for use in long-term monitoring of oxygen use and carbon dioxide production. Sensor instability is less than 2% per 24 hours (29) , but this error is reduced substantially by recalibration of the machine after each 8 to 10 hours and by repeated observations. In the current study, waking metabolic data were recorded for 20 minutes immediately after awakening after the first night in the laboratory. Metabolic data were also collected for 20 minutes immediately after each of the six MSLT evaluations. This placement gave a standard rest period before the initiation of all of these metabolic measurements. Additionally, 20 minutes of waking metabolic data were collected before lights out on the second night and throughout the entire second night of sleep. For all metabolic observations, carbon dioxide production (VCO 2 ), oxygen consumption (VO 2 ), and respiratory quotient, among other variables, were automatically averaged and saved by the metabolic cart at the end of each minute during the metabolic observation periods. In addition, the metabolic cart generated a time code that was used to stamp each metabolic observation and was also automatically written onto the polygraph paper so that metabolic data could be associated with ongoing EEG on a minute by minute basis. For this report, only VO 2 data are summarized. VCO 2 data were very highly correlated with the VO 2 data and therefore are not reported (30) . The metabolic data from each pair of subjects were matched minute by minute throughout daytime and nighttime metabolic observation periods starting at the first morning metabolic observation.
For waking metabolic observations, Ss remained in bed and were instructed to move as little as possible. The lights in the room were turned on. However, reading or other activities involving movement or increased muscle tone were not allowed. During all waking metabolic recordings, EEG was recorded to ensure that sleep did not occur. During all metabolic observations, Ss also were monitored by video camera to assure compliance with the protocol (ie, no change in posture or removal of mask). Sections of recording scored as "no breathing" were removed before data analysis. As such, all remaining observations during the study should have fallen under the generally required assumption of steady state conditions for the meaningful collection of metabolic data. 
Analyses
Subjects were matched by age, weight, and sex specifically to allow within subject-pair comparisons. As such, paired t tests or repeated-measures analyses of variance (ANOVA) were performed on the paired data. When there were multiple observations points, such as from the MSLT, metabolic measurements, or some performance and mood tests, data were analyzed by ANOVA with terms for condition (SSM insomnia or normal), time of test [df dependent on number of administrations of a given test), and interaction. Pairwise comparisons were performed with the Newman-Keuls test at the .05 significance level using the Huynh-Feldt corrected degrees of freedom. When interaction F values were not statistically significant, the interaction variance was pooled with the error variance to test the main effects. All reported results in the text will refer to statistically significant differences (p <.05) except where noted otherwise.
ANOVA had a term for night (Nights 1 and 2) and group. Only the F values for the group effect were significant, and they are presented in Table 3 . Table  3 also presents the 2-night mean for EEG and subjective data for the laboratory nights for the groups. The average of the standard deviations from the first and second nights is also presented. The SSM patients did not differ significantly from the normals on any EEG sleep variable. As expected, the SSM patients estimated that their sleep latency was significantly longer than the normals (52 vs 24 minutes), that their sleep time during the night was significantly shorter than the normals (6.8 vs 7.5 hours), and that their
RESULTS
Seventy patients with a primary complaint of insomnia participated over a 2.5-year period. By previously published criteria (1), 19 patients were defined as having psychophysiological insomnia, and, by the criteria in this report, 11 patients were defined as having SSM. Of the patients with SSM, nine patients could be matched with normal sleepers, and data from these nine pairs are reported here.
Demographic data are presented in Table 2 . Ss were closely matched in age (32 vs 33 years of age) and weight (169 vs 172 pounds). Body Mass Index (BMI) was similar in the two groups (23.7 vs 25). Two of the nine subject pairs were women. As expected, the SSM patients judged their usual sleep latencies to be longer, their total sleep time to be less, and their total wake time to be longer than the matched normals.
An analysis of variance was performed on the EEG and subjective sleep data from the two groups. The sleep quality was significantly worse than the normals. Table 4 shows mood, performance, and MSLT data from the groups. The SSM patients reported significantly increased Tension and Confusion compared with the matched normal subjects. For the Depression and Anger subscales, a significant group by time interaction was found. Pairwise comparisons revealed that Depression was increased in the SSM patients at all five observation points. For the Anger subscale, Anger was significantly higher in the SSM patients than in the controls at four of the five observation points (the groups did not differ at 8:00 PM). The only significant difference found on the performance measures between the SSM patients and normals was on vigilance sensitivity, where performance was improved significantly in the normals. The SSM patients had MSLT values that were slightly higher than those for the normals (10.2 vs 9.6 minutes), but this difference was not significant. No statistical difference was found in daytime oral temperature in the two groups.
MMPI data from the groups is presented in Table  5 . Scores for the SSM patients were significantly more in the pathological direction for hypochondriasis (HS), psychasthenia (PT), and schizophrenia (SC) than for the matched control Ss.
Metabolic measurements were averaged and saved by the metabolic cart for each minute during the second night and during daytime observations. The mean VO Z for each of the eight waking metabolic measurements and the mean VO 2 for each hour during the sleep period were entered into a repeatedmeasures ANOVA with repeated terms for the matched subjects (1 df) and time (15 df) . The time by group interaction was not significant (NS) (F(15,12O) = 1.13, NS), but both of the main effects were significant. VO 2 overall was increased in the SSM patients as compared with their matched controls (F(1.143) = 45.22, p <.00l). The overall means for the groups were 304 ml/min. (SD 26) and 286 ml/ min. (SD 34). The VO 2 data are plotted in Figure 1 . These data were not well-fit with a 3-degree polynomial approximation because of the rapid decrease in VO 2 at sleep onset. Additionally, the data compare resting daytime V0 2 and nocturnal, primarily sleeping, V0 2 . As such, separate follow-up analyses of variance were performed for the eight daytime observation points and the mean for each of the eight hourly night time observation periods. These ANOVAs were similar to the initial ANOVA in that neither had a significant group by time interaction although both had significant main effects for group and time. In the ANOVA for the daytime VO 2 , the F value for the comparison of normals and SSM patients was F(l,7l) = 41.24, p <.001 (respective means were 331 ml/min and 307 ml/min). For the sleep data, the corresponding group main effect was F(l,71) = 9.74, p <.005 (respective means were 277 ml/min and 266 ml/min). The specific relationship between metabolic rate and misperception of sleep parameters was explored also by calculating two correlations. The difference in nocturnal metabolic rate between each of the nine pairs of Ss was correlated with the difference in perceived sleep latency and total sleep time on the metabolic observation night. The correlation between increase in metabolic rate and perception of increased sleep latency was not significant (r 7 = .14, NS), and the correlation between increase in metabolic rate and the perception of decreased total sleep time (r 7 = .65) approached significance at the p <.O5 level (r = .67 was required).
DISCUSSION
The data in Tables 2 and 3 primarily document success in identifying SSM patients and normals based on the study entry criteria. As shown, the groups were comparable in the matched parameters and had expected similarity in EEG parameters and dissimilarity in subjective sleep parameters. Both groups had short sleep latencies, high sleep efficiencies, and about 20% REM sleep on both laboratory nights with no evidence of a first night effect. However, the lack of improved sleep on the second night could be, in part, because metabolic measures, requiring the subject to wear a plastic mask over the nose and mouth, were made only on the second night and may have disturbed sleep enough to remove the appearance of a first night effect.
As expected from the difficulty in clinically differentiating SSM patients from psychophysiological insomnia patients, evidence of psychopathology and degraded mood was seen in the SSM patients. Metabolic rate, as measured by 24-hour VO 2 , was significantly increased in the SSM patients as compared with normals, and a significant increase was found in both the nocturnal measurements and in the daytime observations. The overall 6% increase in VO 2 was not as large as the 9% increase reported in a comparison of psychophysiological insomniacs to matched normals in another study (1) . However, the 24-hour increase in metabolic rate, like the 24-hour increase seen in psychophysiological insomniacs, implies that SSM patients have a problem that is not completely linked to the sleep period and that may have direct underlying physiological causes or correlates.
Salin-Pascual et al. (18) placed SSM patients in a transitional state between normal and traditionally described insomnia based on analysis of sleep stage differences. Although the SSM patients in the current study were not matched with true psychophysiological insomniacs so that data from the three groups of subjects could be analyzed together, the data from the current study support the hypothesis presented by Salin-Pascual et al. (18) . The pattern of results in the current study, when examined in relation to the pattern of results in insomniacs following the same protocol, indicate that the values for the SSM patients frequently fell between the values reported for normals and insomniacs (l). In addition to the difference in metabolic rate data discussed previously, results from the SSM patients for MSLT, vigilance, short-term memory, subjective vigor, and subjective estimates of sleep variables and sleep quality also changed in a graded fashion from normals to SSM insomniacs to psychophysiological insomniacs (1). The result from the MSLT is of interest because it is the opposite of what one might predict based on patient complaints and total sleep time. Although the differences between normals and SSM patients on several of these measures were not statistically significant, it is noteworthy that SSM patients had values in the same direction as the insomniacs (ie, were never "better" than the normals) on metabolic rate and all 20 variables in Tables  4 and 5 .
It is relevant that the subjective sleep estimates of the SSM patients were comparable to the values obtained from the slightly older group of psychophysiological insomniacs (1), because this indicates that the subjective impression of sleep in these patients was roughly equivalent to that of insomniacs despite normal EEG parameters. On most POMS scales, the mood ratings from the SSM patients were a bit more extreme than those reported by the psychophysiological insomniacs (1) . In general scores for the SSM patients were comparable with the psychophysiological insomniacs for the neurotic triad measures on the MMPI (l). However, the SSM patients tended to have higher scores than the psychophysiological insomniacs for the PT, SC, and hypomania (MA) scales. Although these data could be interpreted as indicating mood dysfunction of an equal or greater degree in SSM patients as compared with insomniacs, it is also relevant that similar global changes in these same mood variables were reported in a group of normal young adults when they were given large doses of caffeine to induce physiological activation (19) .
The current results establish SSM as a disorder with a physiological basis as opposed to a pure psychological disorder or an artifact of measurement. Studies have shown that benzodiazepines can reduce physiological activation as measured by metabolic rate (31) and body temperature (32) . A separate group of studies found that benzodiazepines improve the perception of sleep in groups of insomniacs but not in normal sleepers (33-35). It is unlikely that the reported changes are secondary to amnesia or other medication-specific effects because this would not predict that the insomniacs would improve their perception of sleep, whereas the normals did not change (35). Therefore, these studies as a whole imply that benzodiazepines improve the perception of sleep in patients by normalizing their level of arousal (36). There is additional evidence that sleep at increased metabolic rates may be less restorative than sleep at lower metabolic rates (28). However, the long-term consequences of the increased arousal associated with SSM are unknown as is the potential value of treatment with benzodiazepines or other medications that could decrease metabolic rate and improve perceived sleep.
